Albion Financial Group UT Lowers Stock Position in Xylem Inc. $XYL

Albion Financial Group UT trimmed its holdings in shares of Xylem Inc. (NYSE:XYL) by 35.6% during the 3rd quarter, according to the company in its most recent Form 13F filing with the Securities & Exchange Commission. The firm owned 9,076 shares of the industrial products company’s stock after selling 5,013 shares during the quarter. Albion Financial Group UT’s holdings in Xylem were worth $1,339,000 as of its most recent SEC filing.

A number of other hedge funds also recently bought and sold shares of the stock. Hanson & Doremus Investment Management increased its holdings in shares of Xylem by 0.9% in the 2nd quarter. Hanson & Doremus Investment Management now owns 8,516 shares of the industrial products company’s stock valued at $1,102,000 after acquiring an additional 77 shares during the period. Princeton Global Asset Management LLC boosted its position in Xylem by 2.1% during the second quarter. Princeton Global Asset Management LLC now owns 3,801 shares of the industrial products company’s stock valued at $492,000 after purchasing an additional 79 shares in the last quarter. Private Trust Co. NA boosted its position in Xylem by 22.4% during the third quarter. Private Trust Co. NA now owns 459 shares of the industrial products company’s stock valued at $68,000 after purchasing an additional 84 shares in the last quarter. Apollon Wealth Management LLC grew its stake in Xylem by 0.5% in the third quarter. Apollon Wealth Management LLC now owns 17,913 shares of the industrial products company’s stock valued at $2,642,000 after purchasing an additional 92 shares during the last quarter. Finally, Wedmont Private Capital raised its holdings in Xylem by 4.6% in the third quarter. Wedmont Private Capital now owns 2,274 shares of the industrial products company’s stock worth $337,000 after purchasing an additional 99 shares in the last quarter. Hedge funds and other institutional investors own 87.96% of the company’s stock.

Xylem Trading Down 0.3%

Shares of Xylem stock opened at $138.42 on Tuesday. The stock has a market cap of $33.70 billion, a PE ratio of 35.58, a price-to-earnings-growth ratio of 2.15 and a beta of 1.18. The firm has a fifty day moving average price of $143.03 and a 200 day moving average price of $140.02. Xylem Inc. has a 1 year low of $100.47 and a 1 year high of $154.27. The company has a debt-to-equity ratio of 0.17, a current ratio of 1.96 and a quick ratio of 1.50.

Xylem (NYSE:XYL) last announced its quarterly earnings results on Tuesday, October 28th. The industrial products company reported $1.37 earnings per share for the quarter, topping the consensus estimate of $1.23 by $0.14. Xylem had a return on equity of 10.77% and a net margin of 10.66%.The company had revenue of $2.27 billion for the quarter, compared to the consensus estimate of $2.22 billion. During the same period last year, the firm earned $1.11 EPS. The firm’s revenue for the quarter was up 7.8% compared to the same quarter last year. Xylem has set its FY 2025 guidance at 5.030-5.080 EPS. Equities research analysts predict that Xylem Inc. will post 4.65 earnings per share for the current year.

Xylem Dividend Announcement

The company also recently announced a quarterly dividend, which was paid on Tuesday, December 23rd. Stockholders of record on Tuesday, November 25th were given a $0.40 dividend. This represents a $1.60 annualized dividend and a dividend yield of 1.2%. The ex-dividend date was Tuesday, November 25th. Xylem’s dividend payout ratio (DPR) is 41.13%.

Wall Street Analysts Forecast Growth

A number of analysts have recently weighed in on the stock. Zacks Research cut shares of Xylem from a “strong-buy” rating to a “hold” rating in a report on Tuesday, November 18th. Barclays increased their target price on shares of Xylem from $165.00 to $172.00 and gave the company an “overweight” rating in a research report on Wednesday, October 29th. Cowen reaffirmed a “hold” rating on shares of Xylem in a report on Friday, December 5th. Argus set a $170.00 price objective on Xylem in a report on Wednesday, October 29th. Finally, Robert W. Baird set a $178.00 price objective on Xylem in a research report on Wednesday, October 29th. Eight analysts have rated the stock with a Buy rating and five have assigned a Hold rating to the stock. According to MarketBeat, Xylem has a consensus rating of “Moderate Buy” and a consensus target price of $167.40.

Insider Buying and Selling

In other news, EVP Claudia S. Toussaint sold 10,421 shares of the company’s stock in a transaction that occurred on Thursday, October 30th. The stock was sold at an average price of $152.64, for a total value of $1,590,661.44. Following the completion of the sale, the executive vice president directly owned 31,250 shares in the company, valued at $4,770,000. This represents a 25.01% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, Director Victoria D. Harker sold 1,700 shares of the company’s stock in a transaction dated Tuesday, November 4th. The shares were sold at an average price of $148.14, for a total transaction of $251,838.00. Following the completion of the sale, the director directly owned 16,875 shares of the company’s stock, valued at $2,499,862.50. This represents a 9.15% decrease in their position. Additional details regarding this sale are available in the official SEC disclosure. Insiders own 0.27% of the company’s stock.

About Xylem

Xylem Inc (NYSE: XYL) is a global water technology company that designs, manufactures and services engineered systems and equipment for the transport, treatment, testing and efficient use of water. Its product portfolio spans pumps and pumping systems, valves, filtration and disinfection equipment, sensors and analytical instruments, and digital solutions for monitoring and control of water infrastructure. Xylem serves the full water cycle with offerings for water and wastewater utilities, industrial customers, commercial and residential buildings, and agricultural applications.

The company was established as an independent publicly traded company in 2011 following a corporate spin-off from ITT Corporation and is headquartered in Rye Brook, New York.